Table 3.
Demographic and clinical data
| Group | Age (years) (mean, SD, range) | Gender (M:F) | Handedness (R:L) | Tumor location | WHO tumor grade | Histological type |
|---|---|---|---|---|---|---|
|
Healthy controls (n = 14) |
37.9 (12.7, 27–68) | (8:6) | (13:1) | – | – | – |
|
Tumor patients Verio (n = 23) |
37.2 (12.7, 20–56) | (16:7) | (20:3) |
LFL: 6 LTL: 5 L Ins: 2 RFL: 4 RTL: 4 R Ins: 2 |
I: 1 II: 9 III: 10 IV: 2 N/A: 1a |
Astrocytoma: 14 Oligodendroglioma: 5 Glioblastoma: 2 DNET:1 N/A: 1a |
| Tumor patients Prisma (n = 26) | 42.2 (13.3, 19–70) | (13:13) | (24:2) |
LFL: 9 LTL: 4 L Ins: 3 RFL: 2 RTL: 3 R Ins: 5 |
I: 0 II: 14 III: 8 IV: 4 |
Astrocytoma: 15 Oligodendroglioma: 5 Glioblastoma: 5 Diffuse glioma NOS: 1 |
|
Tumor patients Trio (n = 22) |
46.4 (14.7, 27–69) | (11:11) | (20:2) |
LFL: 9 LTL: 4 L Ins: 1 L PL: 2 RFL: 3 RTL: 0 R Ins: 2 R PL:1 |
I: 0 II: 11 III: 7 IV: 4 |
Astrocytoma: 12 Oligodendroglioma: 5 Glioblastoma: 4 Gliomatosis: 1 |
M male, F female, DNET dysembryoplastic neuroepithelial tumor, NOS not otherwise specified, L left, R right, FL frontal lobe, TL temporal lobe, PL parietal lobe, Ins insula, WHO World Health Organization
aOne patient initially refused all surgical treatment including biopsy, opting for watch-and-wait. This patient later showed radiological transformation, at which time biopsy confirmed an anaplastic astrocytoma